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Abstract
 
T cell development is dependent on the integration of multiple signaling pathways, although
few links between signaling cascades and downstream nuclear factors that play a role in thymocyte
differentiation have been identified. We show here that expression of the HMG box protein
TOX is sufficient to induce changes in coreceptor gene expression associated with 
 
 
 
-selection,
including 
 
CD8
 
 gene demethylation. TOX expression is also sufficient to initiate positive selection
to the CD8 lineage in the absence of MHC–TCR interactions. TOX-mediated positive selection
is associated with up-regulation of Runx3, implicating CD4 silencing in the process. Interestingly,
a strong T cell receptor–mediated signal can modify this cell fate. We further demonstrate that
up-regulation of TOX in double positive thymocytes is calcineurin dependent, linking this
critical signaling pathway to nuclear changes during positive selection.
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Introduction
 
The thymus generates a vast excess of cells that fail to
complete maturation and die in situ as a result of stringent
selection processes, including 
 
 
 
-selection and positive selec-
tion (1). 
 
 
 
-Selection refers to the requirement for productive
rearrangement of TCR
 
 
 
 chain genes and expression of a
pre-TCR to induce the survival, proliferation, and differ-
entiation of precursor thymocytes. Positive selection operates
at a subsequent stage of development, requiring productive
rearrangement of TCR
 
 
 
 chain genes and TCR-mediated
recognition of self-MHC to induce cell survival and con-
tinued thymocyte maturation.
Both 
 
 
 
-selection and positive selection elicit stable changes
in gene expression. Among the best characterized of these
changes is expression of the 
 
CD4
 
 and 
 
CD8
 
 coreceptor genes,
with 
 
 
 
-selection inducing a CD4
 
 
 
8
 
 
 
 (double negative
[DN]) to CD4
 
 
 
8
 
 
 
 (double positive [DP]) phenotypic change
in thymocytes and positive selection inducing a DP to
CD4
 
 
 
8
 
 
 
 or CD4
 
 
 
8
 
 
 
 (single positive [SP]) transition. A great
deal of work has focused on identifying the pre-TCR– and
TCR-mediated signals that are involved in 
 
 
 
-selection
and positive selection, respectively (2). In addition, there have
been significant advances in understanding the regulation of
coreceptor genes during thymic selection (3). In particular,
members of the Ikaros and 
 
Runt
 
 domain transcription factor
families have been demonstrated to bind regulatory regions
of the 
 
CD8
 
 and 
 
CD4
 
 gene loci, respectively. Ikaros is
thought to activate 
 
CD8
 
 gene expression by increasing the
accessibility of other transcription factors to the locus (4),
whereas Runx1 and Runx3 function to repress 
 
CD4
 
 gene
expression by binding to a silencer regulatory element (5).
In addition, components of mammalian SWI/SNF-like
BAF chromatin remodeling complexes have been impli-
cated in the control of 
 
CD4
 
 and 
 
CD8
 
 gene expression at
various stages of T cell development (6–8).
Although the mechanistic details are still in dispute, data
are accumulating that cell fate decisions associated with
positive  selection are regulated to some degree by the
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 CD8ISP, CD4
 
 
 
CD8
 
 
 
 immature single
positive thymocyte; Cn, calcineurin; DN, CD4
 
 
 
8
 
 
 
 double negative thy-
mocyte; DP, CD4
 
 
 
8
 
 
 
 double positive thymocyte; HMG, high mobility
group; MAPK, mitogen-activated protein kinase; SP, CD4
 
 
 
8
 
 
 
 or
CD4
 
 
 
8
 
 
 
 single positive thymocyte; Tg, transgenic; TOX, thymocyte
selection-associated HMG box protein.
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“length and strength” of intracellular signaling, with CD4
lineage commitment associated with stronger or more pro-
longed signaling than CD8 lineage commitment (9–17).
The mitogen-activated protein kinase (MAPK) signaling
pathway has been implicated in playing a central role in this
process (11, 16–19). Ultimately, however, understanding
lineage commitment necessitates knowledge of how quanti-
tatively or qualitatively different signaling networks imprint
distinct patterns of gene expression in the cell. One gene
target of the MAPK pathway in the thymus, encoding the
Egr-1 transcription factor (20), has been further linked to
regulation of Id3 (21, 22), an inhibitor of E protein tran-
scriptional activation that is required for positive selection
(23). However, few other links between signaling pathways
and transcriptional regulators of positive selection are known.
Calcineurin (Cn) is a calcium-activated serine/threonine
phosphatase composed of catalytic (A) and regulatory (B)
subunits. Two catalytic subunits, CnA
 
 
 
 and CnA
 
 
 
, are ex-
pressed in developing thymocytes. It has been known for
more than a decade that positive selection is inhibited by
the immunosuppressive agent and potent Cn inhibitor cy-
closporin A (24, 25). More recently, genetic approaches
have confirmed that Cn activation is required for positive
selection. Although T cell development proceeds normally
in mice that are deficient in CnA
 
 
 
 (26), positive selection is
inhibited in mice deficient in CnA
 
 
 
 (27). Conversely, ex-
pression of a constitutively active form of Cn in thymocytes
has been reported to enhance positive selection (28). Acti-
vated Cn is known to bind and dephosphorylate NFATs in
the cytoplasm, resulting in nuclear translocation of these
transcriptional regulators (29). An active form of NFATc3
has been shown to substitute for calcium-mediated signals in
the differentiation of a thymocyte cell line (30). However,
the relevant targets of NFATs in the context of positive se-
lection in the thymus are not known.
We have recently described a nuclear protein of the high
mobility group (HMG) box family, thymocyte selection-
associated HMG box (TOX), that is up-regulated during both
 
 
 
-selection and positive selection in the thymus (31). Trans-
genic mice that express TOX (TOX-transgenic [Tg]) in the
majority of thymocytes show a significant increase in TCR
 
 
 
CD8SP thymocytes and a concomitant reduction in CD4
SP thymocytes. Moreover, the production of CD8SP thy-
mocytes in these animals is class I MHC independent. In this
study, we demonstrate that expression of TOX can elicit
changes in coreceptor expression at both the DN and DP
stages that mimic aspects of both 
 
 
 
-selection and positive
selection, respectively. Moreover, production of TCR
 
 
 
CD8SP thymocytes in TOX-Tg mice is independent of
both class I and class II MHC, indicating that expression of
this nuclear factor is sufficient to initiate a differentiation pro-
gram to the CD8 lineage. The CD8SP thymocytes in TOX-
Tg/MHC–deficient (MHC
 
o
 
) animals have down-regulated
expression of the 
 
CD4
 
 gene and up-regulated expression of
Runx3, a transcriptional regulator involved in 
 
CD4
 
 gene si-
lencing. We also demonstrate that regulation of the TOX
gene in DP thymocytes is downstream of Cn signaling, link-
ing this signaling pathway to changes in coreceptor gene ex-
pression. Interestingly, development to the CD8 lineage in
TOX-Tg mice can be overcome by TCR-mediated signal-
ing in vivo. These results are discussed in the context of a
model where lineage commitment during positive selection
is regulated by an integration of MAPK and Cn signaling,
the latter pathway involving up-regulation of TOX.
 
Materials and Methods
 
Animals.
 
All mice were bred at the Scripps Research Institute
and kept under specific pathogen-free conditions. The mice used
in this study were RAG-1 deficient (32), RAG-2 deficient (33),
TCR
 
 
 
 deficient (34), MHC deficient (35), 2C TCR-Tg (36) on
a B6 background, AND TCR-Tg (37) on an H-2
 
b
 
 or H-2
 
b/k
 
background, DO11.10 TCR-Tg (38) on an H-2
 
d
 
 background,
and CnA
 
 
 
 deficient (27).
 
Flow Cytometry.
 
Thymocytes were stained as described previ-
ously (31) and analyzed on a FACScan or FACSort using Cell-
Quest software (Becton Dickinson). Typically, 5,000–20,000
viable cells were acquired based on their forward and side light
scatter, and the log fluorescence is shown. For isolation of specific
thymocyte subsets, cell populations were sorted using FACStar
Plus or FACS
 
®
 
 Vantage DiVa I cell sorters (Becton Dickinson).
Fluorescein isothiocyanate-conjugated anti-CD8
 
 
 
 (53–6.7; eBio-
science), phycoerythrin-conjugated or peridinine chlorophyll
protein–conjugated anti-CD4 (L3T4; eBioscience), phycoerythrin-
conjugated anti-CD8
 
 
 
 (53–5.8; BD Biosciences), phycoerythrin-
conjugated anti–heat stable antigen (HSA) (30-F1; eBioscience),
phycoerythrin-conjugated anti-CD44 (1M7; eBioscience), allo-
phycocyanin-conjugated anti-CD25 (PC61; eBioscience), bio-
tinylated or allophycocyanin-conjugated anti-TCR
 
 
 
 (H57
 
 
 
597;
BD Biosciences), phycoerythrin-conjugated or biotinylated anti-
CD69 (H1.2F3, BD Biosciences) mAbs were used for flow
cytometry.
 
RT-PCR.
 
Total RNA was isolated from sorted DP and
CD8
 
 
 
CD4
 
lo/
 
 
 
 thymocytes from TOX-Tg/MHC
 
o
 
 mice using
the RNeasy RNA kit (QIAGEN). Primer pairs (Invitrogen) used
were: CD8
 
 
 
 5
 
 
 
-TGCCATGAGGGACACGAATAATAAG-3
 
 
 
and 5
 
 
 
-TAAATATCACAGGCGAAGTCCAATC-3
 
 
 
; CD8
 
 
 
5
 
 
 
-TTCTTGGTTGGGGCAGTTGTAGGAA-3
 
 
 
 and 5
 
 
 
-TGG-
CTCTGGCTGGTCTTCAGTATGA-3
 
 
 
; CD4 5
 
 
 
-CTGATG-
TGGAAGGCAGAGAAGGATTC-3
 
 
 
 and 5
 
 
 
-CAGCACGCA-
AGCCAGGAACACTGTCT-3
 
 
 
; TCR
 
 
 
 5
 
 
 
-TGGGGCCATT-
GCCTGGAGCAACCAGA-3
 
 
 
 and 5
 
 
 
-CACAGCCTCAGCG-
TCATGAGCAGGT-3
 
 
 
; Thy-1 5
 
 
 
-CGTACCGCTCCCGCG-
TCACCCTCTCC-3
 
 
 
 and 5
 
 
 
-GCAGGCTTATGCCGCCAC-
ACTTGACCA-3
 
 
 
; and 
 
 
 
-actin 5
 
 
 
-GGCAACGAGCGGTTC-
CGATGCCCTGA-3
 
 
 
 and 5
 
 
 
-GCCAGGATGGAGCCACCG-
ATCCACA-3
 
 
 
.
 
DNA Methylation Assay.
 
Genomic DNA was isolated from
sorted thymocytes using the DNeasy tissue kit (QIAGEN) and
digested with HhaI or NcoI. 100 ng of DNA template was used
for PCR amplification of the sequence flanking the HhaI and
NcoI sites in the CD8 locus with the primer pair 5
 
 
 
-GCC-
CCAGCCTGCACACCTGGGCTACA-3
 
 
 
 and 5
 
 
 
-GATGT-
TCACAGGACCCTGCTGGCCAAA-3
 
 
 
.
 
In Vitro Activation and Culture of Thymocytes.
 
Thymocytes from
TCR
 
 
 
 chain–deficient (TCR
 
 
 
o
 
) or CnA
 
 
 
-deficient
 
 
 
mice were
isolated and cultured in the absence or presence of 0.2 ng/ml
PMA (Calbiochem) and/or 0.05–0.2 
 
 
 
g/ml ionomycin (Calbio-
chem), with and without inhibitors cyclosporin A (5 
 
 
 
g/ml)
(Sigma-Aldrich) or U0126 (10 
 
 
 
M) (Calbiochem) for 6–8 h at 
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37
 
 
 
C. Cells were analyzed by flow cytometry and/or by West-
ern blot. In other experiments, sorted DP thymocytes from
TOX-Tg/MHC
 
o mice or whole thymocytes from MHCo mice
were cultured for 44 h at 37 C and 10% CO2 in DMEM me-
dium supplemented as described previously (18) and used for
flow cytometric analysis.
Immunoblotting. 3   105 thymocytes were lysed in SDS sam-
ple buffer and subjected to Western blot as described previously
(31). Primary antibodies used were affinity purified rabbit anti-
TOX antibody (150–300 ng/ml) (31), polyclonal anti-Runx
(1:3,000) (39), or anti- -actin (1:5,000) (Ab-1; Oncogene
Research Products). Identification of Runx proteins was con-
firmed by Western blot analysis of transfected cells expressing
Runx1 or Runx3 (unpublished data).
Results
TOX Is Sufficient to Initiate Coreceptor Changes Associated
with  -Selection. DN thymocytes progress through distinct
developmental stages that can be monitored by the expression
of CD44 and CD25; the stages are termed DN1 (CD44 
CD25 ), DN2 (CD44 CD25 ), DN3 (CD44 CD25 ), and
DN4 (CD44 CD25 ) (40). Transition of thymocytes from
the DN3 to the DN4 stage during  -selection requires sig-
naling by the pre-TCR complex (41).
We have reported previously that TOX is up-regulated
in the DN3 blast population as a consequence of  -selection
and subsequently down-regulated before the DP stage (31).
To determine the role of TOX during  -selection, we gen-
erated TOX-Tg mice on a RAG-deficient (RAGo) back-
ground. RAGo thymocytes have a developmental block at
the DN3 stage and severely reduced thymic cellularity due
to the failure to undergo  -selection (33). Although the
thymic cellularity of TOX-Tg/RAGo mice was similar to
that of RAGo mice, the expression of the TOX transgene
resulted in a complex pattern of coreceptor expression (Fig.
1 A). Four distinct cell populations, DN, CD4loCD8 , DP,
and CD8SP thymocytes, were present in these mice. An
identical staining pattern was obtained when cells were
stained for CD4 and CD8 , indicating that the CD8  thy-
mocytes expressed a CD8   heterodimer, as do normal DP
and CD8SP thymocytes (unpublished data).
Expression of TOX on a RAGo background also re-
sulted in the appearance of CD44 CD25lo thymocytes,
consistent with initiation of the DN3 to DN4 transition in
some cells (Fig. 1 A). To determine the developmental re-
Figure 1. TOX induces develop-
ment of coreceptor positive thy-
mocytes in RAGo mice. (A) TOX-
Tg/RAGo thymocytes were stained
for expression of CD4, CD8 ,
CD44, and CD25 and analyzed by
flow cytometry. Percentages of total
thymocytes in each quadrant and
total thymic cellularity are indicated.
(B) CD4 and CD8  expression (dot
plots) on CD25 gated thymocytes
(histogram) in a TOX-Tg/RAGo
mouse. (C) TOX-Tg/RAGo mice
were injected i.p. with PBS or anti-
CD3  antibody, and the thymocytes
were analyzed 5 d later for expression
of CD4 and CD8  or CD44 and
CD25 as in A. (D) Methylation status
of the CD8 locus in thymocytes
from mice with the indicated geno-
type as analyzed by restriction digest
and PCR. CD8   and CD8   thy-
mocyte cell subpopulations were
purified by cell sorting.TOX Links Calcineurin to CD8 Lineage Commitment 1092
lationship between different cell populations, thymocytes
from TOX-Tg/RAGo mice were four-color stained for
CD4, CD8, CD25, and CD44. The TOX-Tg/RAGo DN
and some CD4loCD8  thymocytes were CD44 CD25hi,
similar to the majority DN3 population found in RAGo
thymocytes (Fig. 1 A). In contrast, the majority of DP and
some CD4lo cells displayed intermediate levels of CD25,
consistent with a post-DN3 stage of development (Fig. 1
B). Thymocytes with a CD8SP phenotype are found both
as a DN4 to DP transitional population (CD4 CD8  im-
mature single positive thymocyte [CD8ISP]) and as a prod-
uct of DP thymocytes after positive selection. Surprisingly,
the CD8SP thymocytes in TOX-Tg/RAGo mice were
CD25lo when compared with DP thymocytes in these same
animals, most consistent with a post-DP stage rather than a
CD8ISP stage of development (Fig. 1 B).
Expression of TOX in transgenic animals on a wild-type
background does not block  -selection, nor does it result
in aberrant expression of CD25 on DP or CD8SP thy-
mocytes (31). Thus, it seems likely that the reduction in
CD25 in CD8SP compared with DP cells in TOX-Tg/
RAGo mice represents a developmental progression. The
failure of CD25 to be fully down-regulated in these cells
may reflect the absence of proliferation and/or pre-TCR
Figure 2. TOX induces devel-
opment of CD8SP thymocytes in
the absence of TCR–MHC inter-
actions. (A and B) Expression of
CD4 and CD8  on thymocytes
from mice with the indicated
genotype.  Percentages of total
thymocytes in each quadrant are
indicated. (C) Expression of
TCR , CD69, and HSA on
CD8SP thymocytes gated as in B
from mice with the indicated
genotypes. DP thymocytes from
wild-type mice were used as a
control to set appropriate gates.
The percentage of TCRhi,
CD69 , and HSAlo cells are
shown. (D) Total MHCo thy-
mocytes or sorted DP thymocytes
from TOX-Tg/MHCo mice were
cultured ex vivo and analyzed for
CD4 and CD8  expression by
flow cytometry after 20 or 44 h.
Percentages of total thymocytes
in each quadrant are shown.
Viable yield of TOX-Tg/MHCo
thymocytes was 73% after 20 h
of culture.Aliahmad et al. 1093
signals normally associated with  -selection. In support of
this, anti-CD3  treatment of TOX-Tg/RAGo mice led to
increases in thymic cellularity and loss of CD25 on DP and
CD8SP cells (Fig. 1 C) as it does in RAGo mice (42).
Transcriptional activation of the CD8 gene locus dur-
ing the transition from the DN to DP stage of thymocyte
development is associated with DNA demethylation of
the gene (43). Since expression of TOX was sufficient to
induce up-regulation of both CD8  and CD8  on
DN thymocytes, we asked whether TOX also induced a
change in the methylation status of these loci. A CpG se-
quence that forms part of an HhaI restriction site is found
between the linked CD8  and CD8  genes and is a site
of DNA methylation (43, 44). Methylation status of this
site was assessed by restriction digest of genomic DNA
followed by PCR. In RAGo thymocytes, the CD8 locus
is transcriptionally silent and this site is methylated, as evi-
denced by resistance to digestion with the methylation-
sensitive enzyme HhaI and successful PCR with primers
that flank this site (Fig. 1 D). However, PCR fails after di-
gestion of the DNA with the control enzyme NcoI that
recognizes an adjacent sequence that does not include a
CpG methylation site (Fig. 1 D). In contrast, this site
is partially demethylated in DP thymocytes (total thymo-
cytes from TCR -deficient mice) and is therefore sensi-
tive to HhaI digestion (Fig. 1 D).
To determine if TOX was sufficient to alter the methyla-
tion pattern of the CD8 locus, CD8  and CD8  thy-
mocytes were purified by cell sorting from TOX-Tg/
RAGo mice and analyzed as above. Although the HhaI site
was methylated in CD8  thymocytes and resistant to diges-
tion, the CD8  thymocytes showed partial demethylation,
consistent with activation of the CD8 gene locus (Fig. 1 D).
TOX Is Sufficient to Initiate Coreceptor Changes Associated
with Positive Selection to the CD8 Lineage. We have reported
previously that TOX-Tg mice have increased numbers of
CD8SP thymocytes and reduced numbers of CD4SP thy-
mocytes (31). Production of CD8SP thymocytes in these
mice is not dependent on expression of class I MHC. The
fact that TOX-Tg/RAGo mice also had CD8SP thymo-
cytes and that these cells had down-regulated expression of
CD25 when compared with DP thymocytes in these same
animals, suggested that TOX might be sufficient to initiate
positive selection and  -selection.
To test this, we bred TOX-Tg mice onto a TCR o
background. Thymocytes from TCR o mice are unable to
undergo positive selection and are blocked at the DP stage
of development. However, expression of TOX resulted in
appearance of a pronounced CD8SP subpopulation, even
in the absence of a functional TCR complex (Fig. 2 A). In
contrast, no CD4SP thymocytes were detected in these
mice (Fig. 2 A). The CD8SP thymocytes from TOX-Tg/
TCR o mice were neither functionally nor phenotypically
mature (not depicted). However, in the absence of the
TCR as a marker it was not clear whether these cells were
CD8ISP thymocytes or CD8SP thymocytes that had failed
to undergo complete maturation.
This issue was addressed using MHC class I and II dou-
bly deficient (MHCo) mice, since the thymocytes in these
animals are unable to undergo positive selection but express
the TCR. Thus, CD8ISP and CD8SP thymocytes can be
distinguished by expression of the TCR on the latter. In
contrast to MHCo mice, TOX-Tg/MHCo mice had a pro-
nounced CD8SP population, similar to that seen in TOX-
Tg/TCR o mice (Fig. 2 B). A significant proportion
(48.0%) of these CD8SP thymocytes also expressed the
TCR, indicating that they are not CD8ISP cells (Fig. 2 C).
No TCR  CD4SP thymocytes were present in these mice
(Fig. 2 C and not depicted).
CD69 is a marker of TCR-mediated signaling associated
with positive selection (45). In a normal thymus, approxi-
mately half of the CD8SP thymocytes express CD69 (Fig. 2
C). TOX-Tg mice on a wild-type background also con-
tained CD69  CD8SP thymocytes (Fig. 2 C). However,
few CD8SP thymocytes in TOX-Tg/MHCo mice ex-
pressed CD69, consistent with TCR-independent develop-
ment of these cells. Down-regulation of HSA occurs during
the later stages of SP thymocyte maturation (46). Approxi-
mately 70 and 40% of CD8SP thymocytes in normal animals
and TOX-Tg mice, respectively, were HSAlo (Fig. 2 C).
HSAlo cells were also present among TOX-Tg/MHCo
CD8SP thymocytes, although the extent of down-regula-
tion was reduced compared with wild-type cells (Fig. 2 C).
To definitively demonstrate that DP cells can give rise to
CD8SP cells in the presence of TOX and absence of positive
selection, DP thymocytes were purified by cell sorting and
cultured in vitro (Fig. 2 D). A significant proportion of
TOX-Tg/MHCo DP thymocytes spontaneously down-reg-
ulated CD4 over a 44-h culture period, giving rise to
CD8SP cells (Fig. 2 D, top row). In contrast, DP thymocytes
Figure 3. CD4 gene silencing in TOX-Tg
mice. (A) RT-PCR analysis for expression
of the indicated genes in purified CD8SP or
DP thymocytes isolated from TOX-Tg/
MHCo mice. (B and C) Western blot analysis
for expression of Runx proteins in whole
cell lysates prepared from total thymocytes
or isolated CD8SP cells as indicated. Expres-
sion of  -actin was used as a loading control.TOX Links Calcineurin to CD8 Lineage Commitment 1094
from MHCo mice maintained expression of both CD4 and
CD8 (Fig. 2 D, bottom row). Together, the data demon-
strate that expression of TOX in DP thymocytes is sufficient
to induce down-regulation of CD4 and partial maturation in
the absence of normal positive selection signals.
TOX and Coreceptor Gene Expression. Loss of CD4 ex-
pression during the DP to CD8SP thymocyte transition is
controlled by activation of a silencer element in the CD4
gene locus (47). To determine whether loss of cell surface
CD4 on TOX-Tg/MHCo CD8SP thymocytes reflected a
change in gene expression, RT-PCR was performed on
purified cell populations. No significant difference in ex-
pression of TCR , CD8 , or CD8  genes was observed
when TOX-Tg/MHCo CD8SP and DP thymocytes were
compared (Fig. 3 A). However, CD4 gene expression was
markedly reduced in the CD8SP subpopulation (Fig. 3 A).
Interestingly, some diminution of Thy-1 gene expression
was also apparent in the CD8SP population (Fig. 3 A), an-
other indication of partial maturation of these cells (48).
Recently, the Runx1 and Runx3 proteins have been
demonstrated to regulate the expression of the CD4 gene
by binding to the CD4 silencer element (5). Moreover,
CD8SP thymocytes were absent in mice that were defi-
cient in Runx3 and were heterozygous for a deletion mu-
tant of Runx1 (49). Conversely, the overexpression of
Runx1 in vivo resulted in an increase in the total number
of CD8SP thymocytes (39).
As ectopic expression of TOX also led to an increase in
CD8SP thymocytes, we assessed the levels of Runx pro-
teins in thymocytes from different mouse strains used in
this study (Fig. 3 B). Runx3 is more highly expressed by
CD8SP thymocytes than CD4SP thymocytes (5, 39), con-
sistent with its role in CD4 silencing. Thus, in circum-
stances where almost all the thymocytes were DP or
CD4SP including TCR o, AND TCR-Tg, and MHCo
mice, no Runx3 was detectable (Fig. 3, B and C). In con-
trast, Runx1 was expressed at similar amounts in thy-
mocytes from these mice (Fig. 3, B and C) as expected (5,
50). Conversely, in animals where CD8SP thymocytes
were present including normal mice and especially in class I
MHC-restricted 2C TCR-Tg mice, Runx3 was up-regu-
lated (Fig. 3 B).
To assess the changes induced by expression of TOX
in vivo, we then investigated the levels of Runx proteins
in TOX-Tg thymocytes. TOX-Tg thymocytes expressed
both Runx1 and Runx3, consistent with the production of
CD8SP thymocytes in these animals (Fig. 3 C). Most inter-
estingly, however, CD8SP thymocytes that were produced
in the absence of positive selection in TOX-Tg/MHCo
mice had up-regulated Runx3 and maintained expression of
Runx1 (Fig. 3 C). This indicates that expression of TOX is
sufficient to initiate a sequence of events in developing thy-
mocytes, including CD4 gene silencing and the associated
up-regulation of the CD4 silencer binding protein Runx3.
Figure 4. Expression of TOX
is regulated by Cn activation. (A)
Expression of TOX in TCR o
thymocytes activated with PMA
and ionomycin in the absence or
presence of inhibitors of Cn
(cyclosporin  A, CsA) or MEK
(U0126). Also shown is CD69
expression on cells cultured in
medium (thin line), with PMA
and ionomycin (thick black line),
or with PMA/ionomycin and
U0126 (thick gray line). Expres-
sion of TOX in thymocytes de-
rived from a TOX-Tg mouse is
shown as a control. (B) Expres-
sion of CD4 and CD8  on thy-
mocytes derived from various
animals as indicated (dot plots).
Percentage of total thymocytes
in each quadrant is shown. Ex-
pression of TCR  and CD69
was also analyzed on gated
CD8SP thymocytes, and the
percentage of TCRhi or CD69 
cells is indicated. Expression of
TOX was determined by intra-
cellular staining and flow cytom-
etry (C) in WT (dashed line),
Cno (thin line), and TOX-Tg
(thick line) thymocytes or by
Western blot of whole cell ly-
sates (D). (E) Thymocytes from
TCR o and Cno mice were cultured in medium (lanes 3 and 7) or 0.2 ng/ml of PMA and 0.05 (lanes 4 and 8), 0.1 (lanes 5 and 9), or 0.2 (lanes 6 and
10)  g/ml of ionomycin. TOX-Tg thymocytes were analyzed as a control (lane 1).Aliahmad et al. 1095
TOX Is Downstream of Cn Signaling. The Tox gene was
isolated from DP thymocytes which were cultured with
PMA and ionomycin under conditions that induce cell dif-
ferentiation (31). Both MAPK and Cn signaling are re-
quired for positive selection (as described in Introduction).
To address whether these signaling pathways are also in-
volved in regulation of the Tox gene, we asked whether
one or both pharmacologic activators needed to be present
to up-regulate TOX expression. Cultured TCR o (pri-
marily DP) thymocytes expressed little TOX as assessed by
Western blotting (Fig. 4 A). As expected, PMA and iono-
mycin induced up-regulation of TOX in these cultured
cells (Fig. 4 A). However, PMA alone was a poor activator
of TOX expression, whereas ionomycin alone fully up-
regulated the protein in DP thymocytes (Fig. 4 A). Consis-
tent with these results, cyclosporin A, an inhibitor of Cn,
but not U0126, a MEK antagonist, inhibited up-regulation
of TOX in this system (Fig. 4 A). In contrast, induction of
the MAPK-dependent activation marker CD69 (20, 51)
was inhibited by U0126 (Fig. 4 A).
We also took a genetic approach to analyze the depen-
dence of TOX up-regulation on Cn. The reduction in Cn
signaling in CnA -deficient (Cno) mice results in severe
inhibition of positive selection evidenced by a decrease in
TCR  CD4SP and CD8SP thymocytes (27) (Fig. 4 B).
The incomplete block in positive selection in these animals
is likely due to compensation by CnA . Cno thymocytes
express lower amounts of TOX than wild-type thymocytes
when analyzed by flow cytometry (Fig. 4 C) or by Western
blot (Fig. 4 D). Moreover, the efficacy of induction of
TOX by ionomycin is severely reduced in Cno thymocytes
compared with TCR o thymocytes (Fig. 4 E). The resid-
ual TOX induction is presumably mediated by CnA ,
consistent with a reduction but not complete inhibition of
positive selection in these animals (Fig. 4 B).
If TOX is downstream of Cn signaling one would pre-
dict that loss of the CnA  gene would have no effect on
the production of CD8SP thymocytes in TOX-Tg mice.
To test this, we bred TOX-Tg mice onto a Cno back-
ground. Although expression of TOX did not rescue
CD4SP thymocyte development in Cno mice, there was a
fivefold increase in the frequency of TCR  CD8SP thy-
mocytes in TOX-Tg/Cno mice (Fig. 4 B). In addition,
few CD8SP thymocytes in TOX-Tg/Cno mice expressed
CD69, consistent with their production in the absence of
TCR signaling normally associated with positive selection
(Fig. 4 B).
These results demonstrate that expression of TOX induces
development of a post-DP CD8SP thymocyte population in
the absence of MHC-mediated positive selection. The ques-
tion arises as to why expression of TOX skews development
to the CD8 lineage. CD4SP thymocytes are present in
TOX-Tg mice, although somewhat reduced in number
(31). As shown here, the development of these CD4SP thy-
mocytes is dependent on expression of TCR and MHC and
on Cn (Fig. 2, A and B, and Fig. 4 B). In addition, CD4SP
thymocytes in TOX-Tg mice are indistinguishable pheno-
typically from CD4SP in wild-type mice and show normal
up-regulation of TCR, CD5, and CD69 (31). Thus, TOX is
not sufficient to initiate CD4 lineage commitment, and de-
velopment of the CD4 lineage maintains a requirement for
positive selection even in TOX-Tg mice. Therefore, we
reasoned that CD4SP cells would develop as a result of
TCR-mediated signals that could overcome the ability of
TOX to initiate CD8 lineage development.
We have reported previously that expression of TOX
promoted the appearance of CD8SP cells in class II MHC-
restricted DO11 TCR Tg mice (31) (Fig. 5 A). However,
CD4SP thymocytes were also present in these double trans-
genic animals, raising the possibility that DO11 TCR sig-
naling was only partially effective in competing with TOX.
To test this, we bred TOX-Tg mice to AND TCR-Tg
mice on a selecting background. AND TCR-Tg mice ex-
hibit more pronounced skewing to the CD4 lineage than
DO11 TCR-Tg mice, presumably because of increased af-
finity of the AND TCR for class II MHC expressed in the
thymus. Importantly, when the TOX transgene was ex-
pressed in conjunction with the AND TCR transgene, few
CD8 SP thymocytes were observed (Fig. 5 B).
Discussion
Expression of TOX is transiently up-regulated during
both  -selection and positive selection of thymocytes. In
this study, we demonstrated that enforced TOX expression
was sufficient to induce the differentiation of cells through
these developmental checkpoints as assessed by changes in
coreceptor expression but failed to induce cellular prolifer-
ation normally associated with the DN to DP transition.
This shows a clear split in the downstream effectors that are
sufficient for changes in coreceptor gene expression and
those that initiate cell proliferation during  -selection. The
failure of TOX to induce proliferation of DN thymocytes
also indicates that the vast majority of DP thymocytes that
Figure 5. TCR signaling in vivo competes
with TOX activity. (A and B) Expression of
CD4 and CD8  on thymocytes from indi-
cated mice was analyzed by flow cytometry.
Percentage of total thymocytes in each quad-
rant is shown.TOX Links Calcineurin to CD8 Lineage Commitment 1096
develop in TOX-Tg mice on a wild-type background are
the product of  -selection. Although expression of TOX
was sufficient to induce subpopulations of DP and CD8SP
thymocytes in RAGo mice, these cells maintained interme-
diate levels of CD25 on the cell surface. This is an addi-
tional indication that TOX is an incomplete mimic of pre-
TCR signaling. Similarly, the expression of a stable form of
 -catenin results in development of DP thymocytes in
RAGo mice, with limited proliferation and only partial
down-regulation of CD25 (52).
The  CD8 locus is demethylated in TOX-Tg/RAGo
thymocytes that express CD8 at the cell surface (Fig. 1 D).
In some contexts, demethylation appears to be causative for
CD8 gene expression. Thus, mice lacking the maintenance
DNA methyltransferase Dnmt1 abnormally express CD8  
heterodimer in the    T cell subset (53). Demethylation
may also play an important role in regulation of CD8 gene
expression at the DN to DP transition, although remeth-
ylation is not required for loss of CD8 expression in CD4
T cells (43, 53). In addition to the activation of the CD8
gene, we also observed CD4lo-expressing thymocytes in
TOX-Tg/RAGo mice (Fig. 1 A). Based on the expression
of CD44 and CD25 (Fig. 1 B), it seems most likely that
these cells arise from derepression of CD4 gene expression
in the DN3 population. The fact that ectopic expression of
a single nuclear factor can elicit such a complex collection
of cell phenotypes suggests that timing and cellular context
are critical for the function of TOX.
Changes in CD4 gene expression during T cell develop-
ment are regulated by a silencer element located in the first
intron of the CD4 gene (47). The loss of CD4 gene ex-
pression in TOX-Tg thymocytes subsequent to the DP
stage is consistent with activation of this silencer. TOX is
highly expressed in CD4CD8 double dull thymocytes in
normal mice (31), a post-DP stage at which silencer activity
is also observed (54). Moreover, Runx3 is up-regulated in
CD8SP thymocytes from TOX-Tg/MHCo mice (Fig. 5
C). Runx3 binds the CD4 silencer element and plays a role
in extinguishing CD4 expression in thymocytes committed
to the CD8 lineage (5, 49), further implicating TOX in
CD4 silencing. TOX contains an HMG box, a protein do-
main that bends and unwinds DNA by primarily contacting
the minor groove (55). The crystal structure of Runx1, a
closely related protein to Runx3, revealed that DNA bend-
ing is required in order for this transcription factor to bind
to its recognition sequence (56). Thus, TOX could be in-
volved in both induction of Runx3 and in changing the
conformation of DNA targets to allow Runx factors to
bind and exert their function.
Regulation of coreceptor expression in the thymus is at
least partly regulated by changes in chromatin. Ikaros, a nu-
clear factor that is essential for fetal lymphoid development
and that plays multiple roles during adult T cell develop-
ment (57, 58), has been reported to act as both a transcrip-
tional activator and repressor through interactions with pro-
teins that can alter chromatin structure (59). The repressor
activity of Ikaros is associated with packaging of genes into
transcriptionally silent heterochromatin (60). Interestingly,
the effect of loss of Ikaros on DN thymocytes has some sim-
ilarities with the effects of expression of TOX. In both in-
stances, there is pre-TCR–independent production of DP
thymocytes in the absence of proliferation (58). However,
Ikaros has been demonstrated to be required for the full ac-
tivation of the CD8  locus (4). BAF57, a component of
a SWI/SNF-like chromatin remodeling complex, is an
HMG box protein with a single HMG box motif that is pre-
dicted to bind DNA in a sequence-independent fashion (61)
as is TOX (62). Thymocytes from mice lacking wild-
type BAF57, or its associated ATPase Brg-1, also exhibited
changes in coreceptor expression including derepression of
CD4 in DN thymocytes and impairment of CD8 gene acti-
vation (6–8). Thus, the common thread in the ability of
TOX to induce activation and epigenetic modification of
the CD8 locus in DN cells and activation or silencing of the
CD4 locus in DN or DP cells, respectively, could be the in-
duction of architectural changes in chromatin, as reported
for Ikaros and members of the SWI/SNF-like complex.
This is certainly consistent with the known and proposed
functions for HMG box proteins in transcriptional regula-
tion and nucleosome remodeling (55, 63).
The loss of CD4 gene expression on a subpopulation of
thymocytes in TOX-Tg mice was independent of normal
TCR and MHC-mediated positive selection. This argues
against the possibility that ectopic expression of TOX alters
T cell development as a result of changes in expression of
the TCR or associated signaling proteins (3). We had re-
ported previously a decrease in the CD4SP to CD8SP thy-
mocyte ratio in TOX-Tg mice (31). This phenotype is
now understood by the ability of TOX to promote CD8SP
development in the absence of positive selection. The re-
duction of CD4SP thymocytes in these mice is likely due
to a preemption of normal positive selection by early ex-
pression of the TOX transgene in DP thymocytes.
Positive selection requires TCR-mediated activation of
MAPK and Cn signaling pathways. How these pathways
are integrated by the cell and how they regulate lineage
commitment remains unknown, although a number of
lines of evidence suggest that the MAPK pathway can have
an overriding deterministic effect on the CD4 T cell fate
(11, 16–19). We have shown here that up-regulation of
TOX in DP thymocytes is Cn dependent, providing a link
between this signaling pathway and CD8 lineage commit-
ment. Expression of TOX induced differentiation of
CD8SP thymocytes independent of expression of MHC or
TCR or activation of Cn. However, TOX is not sufficient
to induce CD4SP development under these same condi-
tions, suggesting a requirement for additional downstream
effectors for CD4 T cell development. One such factor,
GATA-3, has been shown recently to promote differentia-
tion of thymocytes to the CD4 fate while inhibiting
CD8SP development (64). Moreover, GATA-3 expression
has been linked with “strong” TCR signaling (64), corre-
lating with previous findings that the strength of TCR sig-
naling can bias lineage commitment decisions.Aliahmad et al. 1097
These data lead to a model where development of CD4
and CD8 lineages each require both MAPK- and Cn-medi-
ated signals. The strength and balance between these signal-
ing pathways determines cell fate. Cn-mediated signaling
during the initiation of positive selection to either T cell lin-
eage results in up-regulation of TOX. Unopposed, TOX
plays a role in CD4 silencing and CD8 lineage commit-
ment, possibly via up-regulation of Runx3 and/or changes
in chromatin structure. However, in the presence of suffi-
cient MAPK signaling and possibly additional Cn-mediated
signals (17) the effect of TOX is negated, leading to CD4
lineage commitment. This model explains why CD4SP de-
velopment is not affected by expression of TOX in circum-
stances where there is a potent TCR signal and where tim-
ing of TCR and TOX expression are coincident, such as in
TOX/AND TCR double Tg mice. We predict that one
function of increased/prolonged signaling during positive
selection to the CD4 lineage is induction or activation of an
inhibitor of TOX. One intriguing possibility is a role for
GATA-3 in this activity. However, since sustained expres-
sion of GATA-3 is not sufficient to divert class I MHC-
restricted developing T cells into the CD4 lineage (64), it
seems unlikely that GATA-3 alone would function in this
regard. Nevertheless, one might predict that the threshold
of signaling that is necessary to compete with TOX will also
be the set point for CD4 lineage commitment (16).
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